CareX Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

CareX General Information

Description

Developer of drugs for metabolic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Strasbourg
  • France
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
7TM Pharma
Corporate Office
  • Strasbourg
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CareX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-May-2006 Completed Startup
3. Early Stage VC (Series B) 03-Aug-2004 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Jun-2002 Completed Startup
1. Seed Round 01-Jan-2001 Completed Startup
To view CareX’s complete valuation and funding history, request access »

CareX Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

CareX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080200527-A1 Obesity, metabolic syndrome, type ii diabetes, cardiovascular disease, osteoarthritis, cancers; mental disorders; sexual and/or reproductive dysfunctions, epilepsy; 5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1h-pyrazole-3-carboxylic acid [3-(1h-tetrazol-5-yl)-propyl]-amide Inactive 17-Jun-2005
EP-1928859-A1 Pyrazole derivates as cannabinoid receptor modulators Inactive 17-Jun-2005
WO-2006133926-A1 Pyrazole derivates as cannabinoid receptor modulators Inactive 17-Jun-2005
WO-2004072042-A2 Quinoline derivative and their use for modulation of lxr activity Inactive 12-Feb-2003
WO-2004072042-A3 Quinoline derivative and their use for modulation of lxr activity Inactive 12-Feb-2003 C07D215/233
To view CareX’s complete patent history, request access »

CareX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CareX Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioMedPartners Venture Capital Minority
Credit Lyonnais Venture Capital Venture Capital Minority
Gimv PE/Buyout Minority
Global Life Science Ventures Venture Capital Minority
Index Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

CareX FAQs

  • When was CareX founded?

    CareX was founded in 2001.

  • Where is CareX headquartered?

    CareX is headquartered in Strasbourg, France.

  • What is the size of CareX?

    CareX has 3 total employees.

  • What industry is CareX in?

    CareX’s primary industry is Drug Discovery.

  • Is CareX a private or public company?

    CareX is a Private company.

  • What is CareX’s current revenue?

    The current revenue for CareX is .

  • How much funding has CareX raised over time?

    CareX has raised $25M.

  • Who are CareX’s investors?

    BioMedPartners, Credit Lyonnais Venture Capital, Gimv, Global Life Science Ventures, and Index Ventures are 5 of 7 investors who have invested in CareX.

  • When was CareX acquired?

    CareX was acquired on 24-May-2006.

  • Who acquired CareX?

    CareX was acquired by 7TM Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process